申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP3505171A1
公开(公告)日:2019-07-03
The present invention provides: a novel use of a specific bicyclic nitrogen-containing heterocyclic compound as a PDE7 inhibitor; a novel bicyclic nitrogen-containing heterocyclic compound having a PDE7 inhibitory effect, a method for producing the compound, a use of the compound, and a pharmaceutical composition containing the PDE7 inhibitor or the compound; and others. More specifically, the present invention provides a PDE7 inhibitor containing the compound represented by the formula (I):
[wherein the symbols have the same meanings as those described in the description] or a pharmaceutically acceptable salt thereof as an active ingredient.
本发明提供了:一种特定含双环氮杂环化合物作为PDE7抑制剂的新用途;一种具有PDE7抑制作用的新型含双环氮杂环化合物、一种生产该化合物的方法、一种该化合物的用途以及一种含有该PDE7抑制剂或该化合物的药物组合物;以及其他。更具体地说,本发明提供了一种含有由式(I)代表的化合物的 PDE7 抑制剂:
[其中符号的含义与描述中的符号相同]或其药学上可接受的盐作为活性成分的 PDE7 抑制剂。